In a move that reshapes access to COVID-19 vaccines, the FDA now requires clinical trials to prove benefits for low-risk groups, while limiting vaccine availability to adults over 65 and those with risk factors like asthma and diabetes.
Don't miss out!
Join more than 13,000 of your neighbors who already receive our informative, independent reporting on climate, health and the environment in their inbox each week.
In a move that reshapes access to COVID-19 vaccines, the FDA now requires clinical trials to prove benefits for low-risk groups, while limiting vaccine availability to adults over 65 and those with risk factors like asthma and diabetes.